ICON PUBLIC LIMITED COMPANY

Public Equity (NASDAQ)Biotechnology ResearchClinical Research OrganizationPublic Company

📍 Dublin, Ireland

StreetZero Signal 62

Be the first to signal interest

About ICON PUBLIC LIMITED COMPANY

ICON plc is a clinical research organization that provides outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. Its offerings include clinical trial management, laboratory services, and consulting. The company is headquartered in Dublin, Ireland and is publicly traded on NASDAQ under the ticker ICLR.

LATEST FUNDINGRule 144

$1.1M

Announced 2026-11-02

TOTAL RAISED2.00B USD

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for ICON PUBLIC LIMITED COMPANY.

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED—

HQDublin, Ireland

Industry

Public Equity (NASDAQ)

Investors

Enterprise Ireland

Key highlights

Provides outsourced clinical trial management and lab services to pharma and biotech firms.
Completed $2.00B Post-IPO Debt round in April 2024.
Received 4.00M EUR grant from Enterprise Ireland in 2021.
Publicly listed on NASDAQ as ICLR with headquarters in Dublin.